The Study of prevalence of anaemia in newly diagnosed breast and gynaecological malignancies in pre and post-menopausal females.
European Journal of Molecular & Clinical Medicine,
2023, Volume 10, Issue 1, Pages 1491-1495
Abstract
To study anaemia in newly diagnosed breast and gynaecological malignancies in pre and post menopausal females.Material and methods: We conducted a prospective, cross sectional and observational study of anaemia in newly diagnosed breast and gynaecological malignancies in pre and post menopausal females. Association between categorical variables was calculated using Chi Square or Fischer Exact test. Association between continuous variables was calculated using Student T test.
Results: Among 55 female patients taken up for the study, 24 were premenopausal and 31 had reached menopause. The prevalence of anaemia in breast (51.6%) and gynaecological (45.1%) malignancies were significantly higher in postmenopausal females. Bleeding was most commonly found in gynaecological malignancy females, while it was significantly absent in breast carcinoma females. Microcytic anaemia (Iron deficiency or blood loss) was the commonest type in the study subjects (50.9%) followed by normocytic (Anaemia of chronic disease) anaemia (23.6%).
Conclusion: 31 among 55 female patients taken up for the study had reached menopause. The prevalence of anaemia in breast and gynaecological malignancies were significantly higher in postmenopausal females and bleeding was most commonly found in gynaecological malignancy. Microcytic anaemia was the commonest type in the study subjects followed by normocytic anaemia
Keywords:
- Article View: 9
- PDF Download: 59